These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19690986)

  • 1. Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.
    Jürgensen S; Ferreira ST
    J Mol Neurosci; 2010 Jan; 40(1-2):221-9. PubMed ID: 19690986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease.
    Small DH; Fodero LR
    J Alzheimers Dis; 2002 Oct; 4(5):349-55. PubMed ID: 12446967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells.
    Guan ZZ; Miao H; Tian JY; Unger C; Nordberg A; Zhang X
    J Neural Transm (Vienna); 2001; 108(12):1417-33. PubMed ID: 11810405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.
    Coulson EJ; May LM; Sykes AM; Hamlin AS
    Neuroscientist; 2009 Aug; 15(4):317-23. PubMed ID: 19458382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR; Hernandez CM; Dineley KT
    Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice.
    Pesavento E; Capsoni S; Domenici L; Cattaneo A
    Eur J Neurosci; 2002 Mar; 15(6):1030-6. PubMed ID: 11918663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL; Nordberg A; Xiu J; Guan ZZ
    Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic spine loss and synaptic alterations in Alzheimer's disease.
    Knobloch M; Mansuy IM
    Mol Neurobiol; 2008 Feb; 37(1):73-82. PubMed ID: 18438727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
    Schliebs R; Arendt T
    J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
    Auld DS; Kornecook TJ; Bastianetto S; Quirion R
    Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease.
    Ma T; Klann E
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):140-148. PubMed ID: 22122128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic dysfunction in Alzheimer's disease.
    Marcello E; Epis R; Saraceno C; Di Luca M
    Adv Exp Med Biol; 2012; 970():573-601. PubMed ID: 22351073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.
    Pettit DL; Shao Z; Yakel JL
    J Neurosci; 2001 Jan; 21(1):RC120. PubMed ID: 11150356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.